{
    "organizations": [],
    "uuid": "ed5dbce9ee1bd0856d5dc997223f9469cbca2d86",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-athenex-announcesresults-of-first/brief-athenex-announcesresults-of-first-cohort-of-phase-i-clinical-trial-of-gastric-cancer-treatment-idUSASB0C1NT",
    "ord_in_thread": 0,
    "title": "BRIEF-Athenex Announces`Results Of First Cohort Of Phase I Clinical Trial Of Gastric Cancer Treatment",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - Athenex Inc:\n* ATHENEX ANNOUNCES ENCOURAGING RESULTS OF THE FIRST COHORT OF PHASE I CLINICAL TRIAL OF ORAXOL AND CYRAMZAÂ® (RAMUCIRUMAB) COMBINATION TREATMENT IN GASTRIC CANCER Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)\n ",
    "published": "2018-01-22T20:07:00.000+02:00",
    "crawled": "2018-01-23T18:18:58.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "athenex",
        "inc",
        "athenex",
        "announces",
        "encouraging",
        "result",
        "first",
        "cohort",
        "phase",
        "clinical",
        "trial",
        "oraxol",
        "ramucirumab",
        "combination",
        "treatment",
        "gastric",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}